SAN FRANCISCO, June 7, 2021 /PRNewswire/ -- Nektar Therapeutics'
(Nasdaq: NKTR) senior management is scheduled to participate in a
virtual fireside chat at the upcoming Goldman Sachs 42nd
Annual Global Healthcare Conference on Tuesday, June 8, 2021 at 2:10 p.m. Eastern Time.
The presentation will be accessible via a webcast through a link
posted on the Investor Events section of the Nektar website:
http://ir.nektar.com/events-and-presentations/events. This Webcast
will be available for replay until July 9,
2021.
About Nektar
Nektar Therapeutics is a
biopharmaceutical company with a robust, wholly owned R&D
pipeline of investigational medicines in oncology, immunology, and
virology as well as a portfolio of approved partnered medicines.
Nektar is headquartered in San Francisco,
California, with additional operations in Huntsville, Alabama and Hyderabad, India. Further information about
the company and its drug development programs and capabilities may
be found online at http://www.nektar.com.
Contact:
For Investors:
Vivian Wu of Nektar Therapeutics
628-895-0661
View original content to download
multimedia:http://www.prnewswire.com/news-releases/nektar-therapeutics-to-participate-in-fireside-chat-at-the-goldman-sachs-42nd-annual-global-healthcare-conference-301306531.html
SOURCE Nektar Therapeutics